Professor Christos Zerefos, Academy of Athens
Christos Zerefos, Head, Research Center for Atmospheric Physics and Climatology, Academy of Athens. President-elect of the General Assembly of the Hellenic Foundation for Research and Innovation (2017). Professor of Atmospheric and Environmental Physics at the Universities of Athens, Thessaloniki, Visiting Professor, Universities of Minnesota and Boston. Samarbeidspartnere (Scientific Collaborator), University of Oslo. He has been known for his research in ozone, UV, ozone-climate interactions and climate extreme events. His research led to important contributions to international agreements such as the Montreal Protocol. Member, Academy of Athens, Academia Europaea, Norwegian Academy of Sciences and Letters, European Academy of Sciences, Russian Academy of Natural Sciences and other distinguished scientific societies. UNESCO Chair Holder on Natural Hazards; Honorary Professor, Physics Department, Aristotle University of Thessaloniki; Honorary Doctorate Degree, Physics Department, University of Patras; Honorary Degree of Doctor of Humane Letters, University division of the American College ANATOLIA, Thessaloniki;Recipient of the UNEP Global Ozone Award, 1997 and a number of distinctions, awards and medals from WMO/UNEP and several scientific societies (e.g. Blaise Pascal Medal, European Academy of Sciences; AGU Kaufman Award; European and Balkan Physics Societies Award; European Union Prize for Cultural Heritage-Europa Nostra Award and others) for his career achievements. In the past 20 years has acted as author, contributor or reviewer in almost all WMO/UNEP Scientific Assessments of Ozone Depletion and reviewer in IPCC Aviation and extreme events reports (1998 and 2013). Award Certificate and Letter from UNEP and IPCC for substantial contribution to the reports of IPCC, which shared the 2007 Nobel Peace Prize with the former Vice President of USA, Al Gore (December 2007).
Prof Andrew Stockman, UCL Institute of Ophthalmology
Professor Stockman holds the Steers Chair of Investigative Eye Research at the UCL Institute of Ophthalmology and is an Honorary Consultant at Moorfields Eye Hospital. Professor Stockman is a leading psychophysicist and expert on testing visual function, who specializes in physiological optics, colour vision, rod vision, visual adaptation, temporal sensitivity, retinal processing and clinical psychophysics. He is probably best-known for his work on human cone spectral sensitivities. The cone spectral sensitivities and the related luminous efficiency function proposed by Stockman and Sharpe, all based on measurements in observers of known photopigment opsin genotype, have now been adopted by the Commission Internationale de l’Éclairage (CIE) as the 2006 and 2015 “physiologically-relevant” international standards for colour definition and colour measurement. These functions are central to modern work on colour vision.
His other important work includes measurement of cone and rod temporal (flicker) sensitivity and delay that has resulted in the identification of “slow” and “fast” signals in photopic and mesopic vision, the discovery of an unexpected S-cone input to luminance, work on rod and cone adaptation and measurement of visible distortion that allows the performance of the visual system to be dissected into early and late stages. This work has led to new models of early visual processing.
As an Honorary Consultant at Moorfields Eye Hospital Professor Stockman is also involved in the visual assessment of clinical patients in several significant collaborations with the Hospital, including experimental work on the effects of specific gene defects in rod and/or cone photoreceptors, and their implications for retinal processing of visual signals in normal vision. He is a Fellow of the Optical Society of America and was recently awarded the Colour Group Newton medal and the Inter-Society Color Council Macbeth award.
Dr. Ireneusz Grulkowski, Nicolaus Copernicus University
Dr. Ireneusz Grulkowski received his MSc (Biomedical Physics – 2003, Biotechnology – 2005) and PhD (Experimental Physics – 2007) from the University of Gdansk, Poland. In 2008 he joined Medical Physics Group at the Nicolaus Copernicus University in Torun, Poland (Prof. M. Wojtkowski). In 2010-2012, Dr. Grulkowski was a postdoctoral fellow (visiting scientist) at the Prof. J. G. Fujimoto lab at the Massachusetts Institute of Technology (Cambridge, MA, USA). In 2016, he obtained habilitation degree in the field of biophysics (bio-optics). He is currently an Assistant Professor at the Nicolaus Copernicus University in Torun, Poland, and the leader of the Bio-Optics and Optical Engineering Lab.
The scientific interests of Dr. Grulkowski’s team include application of novel optical imaging modalities in ophthalmic diagnostics, optical engineering to enhance the performance of optical microscopy tools, and the studies of optical properties of ocular structures etc. Dr. Grulkowski specializes in the development of optical coherence tomography systems for anterior eye imaging. The team performs also many collaborative clinical and fundamental studies with leading research groups from Europe and the US.
Dr. Grulkowski published more than 60 articles in peer-reviewed journals and is the author of 4 chapters in books. He delivered over 100 presentations at the international conferences (including 11 invited talks). He is a life-time member of SPIE, a member of the Optical Society of America and the Association for Research in Vision and Ophthalmology. He has been the mentor of few graduate and post-doctoral students, and serves as an associate editor in ‘Open Physics’ and ‘Sensors’.
Dr. Carsten Laue, President and CEO of InfiniteVision Optics
Dr. Carsten Laue, President and CEO of InfiniteVision Optics since 2013, raised over € 15 million in public and private funding for various start-up companies. He was responsible for the market approval of medical devices in the ophthalmology and bone replacement space. Carsten studied Chemistry at the TU Darmstadt, DE, ETH Zürich, CH, University of Cardiff, UK, Babson College, USA, and obtained a PhD in Natural Science from the EPF Lausanne, CH.
2009 – Visiometrics required more involvement as the company was moving forward very fast. Since he re-joined in an executive roll He has, among other things, implemented a very compelling business model. Visiometrics is now a full organization with presence in over 30 countries, located in both USA, where they manufacture and Spain. Visiometrics has signed several contracts with important multinational companies, like Acufocus and Alphaeon. Agreements and partnerships in important markets like China, Korea, Japan and Europe have also been successfully clinched. He sold Visiometrics to Halma,Plc in late 2015 in a + 100 million Euros deal.
2007- 2009 VP Sales and Marketing at Calhounvision, Inc. . he raised money, took ownership of the commercialization and launched the technology of Light Adjustable Lens technology in Europe. The technology is moving forward with never before seen vision outcomes and is now in phase III FDA trials. He is member of the board of directors of Calhounvision,Inc. , now RxVision,Inc.
2001-2007 CEO of Visiometrics,S.L. High-tech company in the optical and ophthalmic field. Visiometrics is a leading company in the diagnostic market of quality of vision. Together with his team, they accomplished several crucial milestone objectives, such as: obtain FDA approval and CE-Mark approval for a new product called OQAS and also establish distribution and sales all over the globe. Visiometrics is a start-up and a spin-off from the Polytechnic University of Barcelona.
It was very interesting for him to build this business having to deal with all possible ingredients there are in a complex business scenario. From fundraising to local political administration, jumping from possible business exits to establishing a revolutionary technology. Ensuring a safe growth model while making sure that 30 scientists at the University also appreciate that their effort has a true and direct economical impact. The Business Pan written by him, made emphasis of the need of close collaboration with at least 50 world wide opinion leaders to be the first to embrace the concept. Today Visiometrics has many international well known spokesmen for the HD Analyzer.
1997-01 CEO Oftalogic,S.A. a distributor company working as exclusive distributor with several important international brands in the Ophthalmic field, such as,LaserSight, Lenstec,Ophtec, Laser Diagnostics, Refractec, ThinOptx, Feather, Kera-Vision etc. Oftalogic,S.L. became a leader in the Spanish Refractive market with over 20 employees and a 6mill.€/yearly turnover.
1991-1997 CEO Europhtal,S.L. a distributor company acting in Spain and in some other European markets as distributor for Chiron Vision, Technolas, (now B&L) The most remarkable contribution is probably the fact that Europthal was the first company in the world to perform LASIK with Hansatome and Technolas. Jan and Dr.Güell, were the first in the world to promote LASIK , offering LASIK curses to most of the first lasik adapters and more than 200 users all over the world. He also served on the European board of Chiron Vision. Europhtal had an approx. yearly turnover of 1000 Mill. Pesetas
In the early nineties, he accomplished to bring Lasik Surgery to the market, together with a very small select group of people He has also pioneered in the cataract market with Healon and Intraocular Lenses. He is a founding member of ACOS, American society for American and European Ophthalmologists .
1986-1991 He started as Sales Representative to become Marketing Manager at Pharmacia, AB.(later Phizer ,AMO and now Abbot). These were the early days of IOL´s and the Viscoelastic , Healon. This is truly where Jan got involved with ophthalmology both professionally and emotionally. Keeping in mind his previous experience as a teacher and also his newly acquired business skills, at Pharmacia he received an extraordinary technical background. The experience was so good it could be further cultivated over the years, making him probably one of the most technically and clinically skilled top executives in the world today. He also established close relationships with those days upcoming star ophthalmologist, who are now the most prominent opinion leaders in the world. Professional commitments included branding of Healon, the world leading Viscoelastic product and Intraocular lenses to be implanted after Cataract surgery. Together with his team they made several historical % growth/year figures. It is fair to say that in those days the market was exploding from virtually no implantations towards the today standard of 100% implantation. He is proud of having been able to play an important role in this evolution.
2007-08 IESE Business School’s “Advanced Management Program”. This program shares methodology and teachers with the AMP program at Harvard
1988-89 “Dirección de Marketing” at the Barcelona based Business School EADA
1979-83 Economics and foreign languages at the University of Uppsala, Sweden
Jan is fluent in 7 seven languages
He is married with two children, 23 and 19years
He is on 4 Boards of Directors